SCHEMBL21703340

SCHEMBL21703340

CCNc1cccn(Cc2nc3cc(F)ccc3n2Cc2ccccc2)c1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K1 Q92918 6/20 0.47
AGTR1 P30556 1/20 0.47
AGTR2 P50052 1/20 0.47
GNRHR P30968 2/20 0.47
RAB9A P51151 1/20 0.47
ALDH1A1 P00352 5/20 0.45
KDM4E B2RXH2 3/20 0.45
LMNA P02545 2/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
HPGD P15428 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
USP2 O75604 2/20 0.45
CYP1A2 P05177 2/20 0.45
CYP3A4 P08684 2/20 0.45
CASP1 P29466 2/20 0.45
CASP7 P55210 2/20 0.45
HIF1A Q16665 2/20 0.45
HSD17B10 Q99714 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21684642 0.85 TBXA2R (0.48) MAP4K1AGTR1AGTR2GNRHRRAB9A
SCHEMBL21703331 0.85 MAP4K1 (0.53) MAP4K1RAB9AALDH1A1KDM4EMEN1
SCHEMBL21685620 0.81 ALDH1A1 (0.55) AGTR1AGTR2GNRHRRAB9AALDH1A1
SCHEMBL21703186 0.80 TBXA2R (0.50) MAP4K1AGTR1AGTR2RAB9ATBXA2R
SCHEMBL23452789 0.79 MAP4K1 (0.60) MAP4K1ALDH1A1KDM4EMEN1KMT2A
SCHEMBL21684766 0.78 MAP4K1 (0.62) MAP4K1
SCHEMBL24859765 0.77 MAP4K1 (0.45) MAP4K1ALDH1A1KDM4EMEN1KMT2A
SCHEMBL21703339 0.76 BRD4 (0.50) AGTR1AGTR2RAB9AALDH1A1LMNA
SCHEMBL21703260 0.76 MAP4K1 (0.49) MAP4K1AGTR1AGTR2RAB9AKDM4E
SCHEMBL25944269 0.75 MAP4K1 (0.56) MAP4K1ALDH1A1SMN1; SMN2TBXA2RL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020033784-A1 TRANSGLUTAMINASE 2 (TG2) INHIBITORS SITARI PHARMA, INC. (US) 2020-02-13 WO disclosed